
Genesis Therapeutics
Biotechnology, Burlingame, California, 94080, United States, 11-50 Employees
Who is GENESIS THERAPEUTICS
Genesis Therapeutics headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego is unifying AI and biotechnology to discover novel and breakthrough treatments for pa...
Read More

-
Headquarters: Burlingame, California, 94080, United States
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
CEO: Evan Feinberg
Industry: Biotechnology
Does something look wrong? Fix it. | View contact records from GENESIS THERAPEUTICS
Genesis Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Genesis Therapeutics
Answer: Genesis Therapeutics's headquarters are located at Burlingame, California, 94080, United States
Answer: Genesis Therapeutics's phone number is FALSE
Answer: Genesis Therapeutics's official website is https://genesistherapeutics.ai
Answer: Genesis Therapeutics's revenue is $5 Million to $10 Million
Answer: Genesis Therapeutics has 11-50 employees
Answer: Genesis Therapeutics is in Biotechnology
Answer: Genesis Therapeutics contact info: Phone number: FALSE Website: https://genesistherapeutics.ai
Answer: Genesis Therapeutics headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery. The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled discovery and optimization. We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022) and Genentech (signed in 2020). Genesis has raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. We are rapidly growing our team with a variety of openings on our machine learning, computational chemistry, and software teams (primarily located in the Bay Area) and our chemistry, biology, and clinical teams (primarily located in San Diego). To learn more about Genesis Therapeutics, or current employment opportunities, please visit our website.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface

Sign in to CIENCE GO Data to uncover contact details
Free credits every month